课题基金 / 基金详情

STUDY OF ORAL CCII IN TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS

STUDY OF ORAL CCII IN TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS
口服CCII治疗活动性类风湿关节炎的研究
批准号:
6117917
负责人:
MICHAEL H WEISMAN
金额:
$1.46万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MICHAEL H WEISMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Compare clinical response to graded oral doses of CCII to placebo in patients with active rheumatoid arthritis, determine onset, magnitude and duration of beneficial clinical response, and determine safety and tolerability of doses and duration of treatment in patient population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INDUCTION COURSE & MAINTENANCE CYCLE OF AG4263 IN RHEUMATOID ARTHRITIS
LJP 394 ADMINISTERED TO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
RECOMBINANT HUMAN INTERLEUKIN ELEVEN IN RHEUMATOID ARTHRITIS
RO32 3555 TROCADE IN STRUCTURAL JOINT DAMAGE IN RHEUMATOID ARTHRITIS
海外基金